AIRLINK 76.62 Decreased By ▼ -3.38 (-4.23%)
BOP 5.19 Increased By ▲ 0.01 (0.19%)
CNERGY 4.49 Increased By ▲ 0.03 (0.67%)
DFML 35.25 Increased By ▲ 0.09 (0.26%)
DGKC 77.79 Increased By ▲ 0.91 (1.18%)
FCCL 20.25 Increased By ▲ 0.27 (1.35%)
FFBL 36.77 Increased By ▲ 1.17 (3.29%)
FFL 9.55 Increased By ▲ 0.02 (0.21%)
GGL 10.02 Decreased By ▼ -0.14 (-1.38%)
HBL 117.20 Increased By ▲ 0.20 (0.17%)
HUBC 133.02 Increased By ▲ 0.52 (0.39%)
HUMNL 7.04 Decreased By ▼ -0.02 (-0.28%)
KEL 4.61 Decreased By ▼ -0.04 (-0.86%)
KOSM 4.59 Decreased By ▼ -0.06 (-1.29%)
MLCF 37.30 Decreased By ▼ -0.20 (-0.53%)
OGDC 136.33 Increased By ▲ 1.86 (1.38%)
PAEL 23.12 Increased By ▲ 0.22 (0.96%)
PIAA 26.62 Decreased By ▼ -0.01 (-0.04%)
PIBTL 6.70 Decreased By ▼ -0.11 (-1.62%)
PPL 115.26 Increased By ▲ 3.16 (2.82%)
PRL 27.70 Increased By ▲ 0.50 (1.84%)
PTC 14.47 Increased By ▲ 0.09 (0.63%)
SEARL 56.21 Decreased By ▼ -0.18 (-0.32%)
SNGP 68.50 Increased By ▲ 1.50 (2.24%)
SSGC 10.88 Increased By ▲ 0.05 (0.46%)
TELE 9.20 Decreased By ▼ -0.09 (-0.97%)
TPLP 11.02 Decreased By ▼ -0.16 (-1.43%)
TRG 67.35 Decreased By ▼ -1.65 (-2.39%)
UNITY 25.36 Decreased By ▼ -0.13 (-0.51%)
WTL 1.33 Increased By ▲ 0.01 (0.76%)
BR100 7,561 Increased By 38.9 (0.52%)
BR30 24,565 Increased By 162.7 (0.67%)
KSE100 71,960 Increased By 265.2 (0.37%)
KSE30 23,665 Increased By 122.9 (0.52%)

Pfizer Inc

Indian shares rise
Markets

Indian shares rise

BENGALURU: Indian shares ended higher on Monday, led by financial and energy stocks, while Pfizer Inc’s local arm...
Published 09 Nov, 2021 04:48am
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion
Business & Finance

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

  • It is expected to make up for more than one-third of Pfizer's full-year sales, with the company in supply talks with several countries for 2022 and beyond.
  • "Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine - similar to that of the flu vaccines - is a likely outcome," Chief Executive Albert Bourla said in his prepared remarks.
Published 04 May, 2021 07:48pm
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Published 30 Apr, 2021 04:51pm